At a Glance
| Adrafinil | N-Methylbisfluoromodafinil | |
|---|---|---|
| Class | Stimulants, Nootropic, Eugeroics | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 250–400 mg | 100–150 mg |
| Total Duration | 6.3–9 hrs | — |
| Routes | oral | oral |
Adrafinil, a Stimulants, Nootropic, Eugeroics, and N-Methylbisfluoromodafinil, a Stimulants, Nootropic, Eugeroics, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulants, Nootropic, Eugeroicss, meaning they share a common pharmacological foundation. They share 8 documented effects in common, with 1 effects unique to Adrafinil and 11 unique to N-Methylbisfluoromodafinil. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Adrafinil | N-Methylbisfluoromodafinil | |
|---|---|---|
| Class | Stimulants, Nootropic, Eugeroics | Stimulants, Nootropic, Eugeroics |
| Common Dose (oral) | 250–400 mg | 100–150 mg |
| Total Duration | 6.3–9 hrs | — |
| Routes | oral | oral |
| Effects | 9 documented | 19 documented |
| Interaction | Caution | |
| Level | Adrafinil | N-Methylbisfluoromodafinil |
|---|---|---|
| Threshold | 100 mg | 25 mg |
| Light | 150–250 mg | 50–100 mg |
| Common | 250–400 mg | 100–150 mg |
| Strong | 400–600 mg | 150–200 mg |
| Heavy | 600 mg | 200 mg |
Adrafinil
N-Methylbisfluoromodafinil
Increased cardiovascular strain and neurotoxicity risk